Loading
When a trial fails, the company has little commercial reason to keep the detailed data secret. Make sharing it the default rather than something researchers must beg for.
Platforms such as Vivli and YODA share individual participant data on request, but sponsors control access and failed trials are under-represented. Since a discontinued programme has little competitive value, a policy (via funders, journals and regulators) that participant-level data from terminated oncology programmes is deposited with open access after 24 months would unlock meta-analysis, biomarker work and methods research.
Shares Rescue the biological samples from failed trials for biomarker research, Failures are hidden.
Shares Rescue the biological samples from failed trials for biomarker research, Failures are hidden.
Shares Rescue the biological samples from failed trials for biomarker research, Failures are hidden.
Shares Failures are hidden, Data silos.
Shares Failures are hidden, Data silos.
Shares Failures are hidden, Data silos.